From individual health to population hygiene, and from healthcare institutions and their industrial chains to the global medical and health ecosystem, the healthcare sector is undergoing an unprecedented wave of digitalization. With continuous breakthroughs, innovations, and convergence in biotechnology, information technology, new materials, and intelligent manufacturing, how should we reinterpret individual life and health? How can the intricate biological world be captured, interpreted, and computed?
April 16-18, 2021,The 5th Future Healthcare 100 Conferencewill be"The Calculation of Life"as the theme, inSuzhou WujiangMeet with everyone.

Conference Dates: April 16–18, 2021 (Friday–Sunday)
Venue:Suzhou · Wujiang · Le Méridien Hotel
Organizer:VCBeat, VB100, VCBeat Research Institute, Artery Orange
Co-organized by:Wujiang District People's Government, Guangdong Zhong Nanshan Medical Foundation
Co-organizers:Suzhou Wujiang Dongfang State-owned Capital Investment and Operation Co., Ltd.
Exclusive Strategic Partner:Alibaba Health

(Scan the QR code to register and get an instant discount of 100 yuan)

1. The summit will invite more than 30 government officials, scholars, investors, and entrepreneurs to explore the growth of China's general health industry around five major modules;
2、Academician of the Chinese Academy of Sciences, Fan Jia, President of Zhongshan Hospital Affiliated to Fudan University, Confirmed Attendance;
3、Academician Zhang Zhiyuan, Chinese Academy of EngineeringConfirm attendance for the speech;
4、Member of the American Academy of Arts and Sciences, Member of the National Academy of EngineeringShiqing ChenConfirm attendance for the speech;
5、Dean of the School of Materials Science and Engineering, Suzhou University of Science and Technology; Academician of Academia EuropaeaLi ChangmingConfirmed attendance for the speech;
6、Top 5 Hospital PresidentsJointly explore new pathways and emerging demands in the digital transformation of hospitals;
7、5 Top Investment GurusExploring Investment Hotspots and Innovation Value in the Post-Pandemic Era;
8、Alibaba Health, B-Soft, Sansure Biotech, GSK, MGI TechAwaiting guest confirmation of attendance.
| Time | Module | Agenda | Guest |
| Host: Professional Host | |||
| 09:00-09:05 | Opening Ceremony Address | Address at the Conference | Li Datao | Founder of VCBeat |
| 09:05-09:10 | Conference Address | Fan Jia | Academician of the Chinese Academy of Sciences, President of Zhongshan Hospital, Fudan University | |
| 09:10-09:15 | Conference Address | Wang Guorong | Deputy Secretary of the Wujiang District Committee of the Communist Party of China, and Mayor of the People's Government of Wujiang District | |
| 09:15-09:30 | Wujiang Global Promotion Led by Leadership | Chen Jianzhong | Deputy District Mayor of Wujiang District People's Government | |
| 09:30-09:35 | Address at the Conference | Relevant Leaders of the International Exchange and Cooperation Center, National Health Commission | |
| 09:35-09:45 | Conference Address | Sun Baoqing | Chairman of the Guangdong Zhong Nanshan Medical Foundation | |
| 09:45-10:05 | External Variables: Macro Environment and Future Trends | Trends in the Innovation and Development of Medical Robots | Zhang Zhiyuan | Academician of the Chinese Academy of Engineering |
| 10:05-10:25 | Development of the Healthcare System in the Era of Smart Health Trends | Zhang Yuhui | Deputy Director of the Health Development Research Center, National Health Commission | |
| 10:25-10:45 | Leap in Computing Power: Innovation in the Atomic World and the Bit World | The Calculation of Life | Li Datao | Founder of VCBeat |
| 10:45-11:05 | A New Landscape of Internet Healthcare Driven by Cutting-Edge Technologies | Zhu Shunyan | Chairman and CEO of Ali Health | |
| 11:05-11:25 | Applications of Brain Science, AI, and Intelligent Supercomputing in Future Healthcare | Shiqing Chen | Member of the American Academy of Arts and Sciences, Member of the U.S. National Academy of Engineering | |
| 11:25-11:45 | Innovative Applications of Biosensing in Medical Diagnostics | Li Changming | Dean of the School of Materials Science and Engineering, Suzhou University of Science and Technology; Member of Academia Europaea | |
| Lunch Break | |||
| 14:00-14:20 | Value Reconstruction: Digital Leap and Hospital Transformation | Building Healthy Cities, Constructing Future Communities | Ge Hang | Founder and Chairman of B-Health |
| 14:20-14:40 | Opportunities and Challenges for Molecular Diagnostics in the Post-Pandemic Era | Deng Zhongping | Deputy General Manager of Sansure Biotech | |
| 14:40-15:00 | Building a Digital Product Ecosystem Around Gene Sequencers | Shan Riqiang | Chief Information Officer of MGI Tech | |
| 15:00-15:45 | New Pathways and Emerging Demands in the Digital Transformation of Hospitals | Host: Jiang Tianjiao | Dean of VCBeat | |
| Zhang Nuofu | Vice President of the First Affiliated Hospital of Guangzhou Medical University | |||
| Chen Hongxiang | Executive Vice President, Union Shenzhen Hospital of Huazhong University of Science and Technology (Nanshan Hospital) | |||
| Weng Jianping | Deputy Director of the Division of Life Sciences and Medicine, University of Science and Technology of China; President of Bengbu Medical College | |||
| Zhou Weikang | Deputy Director of Chongqing Hospital, University of Chinese Academy of Sciences | |||
| Tao Liang | President, Wuhan Asia Heart Hospital | |||
| 15:45-16:30 | Scenario Validation: Industrial Iteration and Ecosystem Trends | Healthcare Industry Outlook: How to Enhance Quality of Life for More People | Host: Yu Wenxin | Chief Healthcare Analyst, Haitong Securities |
| Zhang Yuhui | Deputy Director of the Health Development Research Center, National Health Commission | |||
| Zhu Shunyan | Chairman and CEO of Alibaba Health | |||
| Wang Xinguang | Vice President, GSK China | |||
| Mystery Guest | |||
| 16:30-17:15 | Investment Hotspots and Innovation Value in the Post-Pandemic Era | Moderator: Xu Xiaolin | Founder of Huagai Capital | |
| Roundtable Guest: Wang Junfeng | Managing Director, Legend Capital | |||
| Xia Wu | Managing Director, CICC Capital | |||
| Li Yuhui | Founding Managing Partner and Chairman, Panlin Capital | |||
| Gan Shixiong | Founding Partner, Shengshan Asset | |||

1. VCBeat joins hands withGeneWisdomCo-hosted event, with over 10 senior executives from relevant industry companies attending to share insights, focusing on product and technological innovation to break through traditional boundaries;
2、Academician of the Chinese Academy of SciencesFan JiaConfirm attendance;
3、KingMed Diagnostics, BGI Group, Agilent Technologies, Huawei Cloud, ChenAn Bio, Rendong Medicine, Wondfo Biotechand other executives have confirmed their attendance;
4、“2021 Blue Book of the Gene Industry”On-site release.
| Time | Agenda | Guest |
| Host | Hao Han | Senior Researcher at VCBeat | |
| 09:00-09:20 | Address | Fan Jia | Academician of the Chinese Academy of Sciences |
| 09:20-09:30 | Launch Ceremony of the "2021 Blue Book on the Gene Industry" | Wang Liang | Founder & CEO, GeneHui |
| 09:30-09:50 | Genetic Testing Enters Its Second Phase: How to Break Through Established Service Circles? | Jin Ge | Founder and CEO of Rendong Medical Group |
| 09:50-10:10 | How to Achieve Precision Prevention and Control of Infectious Diseases in the Post-Pandemic Era | Zhang Yong | Chief Scientist, Yuangu Ji; Visiting Professor, Guangzhou Institute of Respiratory Health |
| 10:10-10:30 | Industry Focuses on the Downstream: The “Dark Horse” of Digital PCR Is Poised to Emerge! | Cao Xinwei | Deputy General Manager of Raybiotech |
| 10:30-11:10 | How Are Production Digitalization and the LDT Window Reshaping the Landscape of Molecular Diagnostics? | Moderator: Wu Kai | Partner, Sinovation Ventures |
| Roundtable Guest: Guo Feng | Founder and CEO of Zhenzhun Bio | ||
| Kang Keren | Executive Vice President of Wondfo Biotech | ||
| Yang Wanfeng | Vice President of KingMed Diagnostics | ||
| Xiaowei Zheng | General Manager, Greater China, Agilent Technologies Diagnostics and Genomics Group | ||
| Shan Riqiang | Chief Information Officer, MGI Tech | ||
| Nie Junwei | Deputy General Manager, Life Sciences Division, Vazyme | ||
| 11:10-11:30 | Single-Cell Technologies Move Toward the Clinic: Do We Need Such High Resolution? | Ji Pengxiang | Vice President of Commercial Applications, ChenAn Biologics |
| 11:30-12:10 | BT-IT Convergence: How to Compliantly Leverage Life Big Data and Empower Product R&D? | Moderator: Wang Liang | Founder and CEO of Genetron Health |
| Roundtable Guest: Wang Jin | Co-founder, QiTan Technology | ||
| Yang Shuang | Executive Vice President, BGI Group | ||
| Meng Xin | Product Director, Huawei Cloud Medical AI Agent | ||
| Wang Tao | CTO, Ruipu Technology | ||
| Wang Chunxiao | Deputy General Manager, TreeGene Genetics | ||

1. Invite experts in this fieldOver 10Unicorn companies and innovative enterprises shared their respective innovation achievements around topics such as commercial insurance, payment, medical insurance, and cross-sector collaboration, while discussing the significant challenges and opportunities facing innovative payment models;
2、Life Capital,Magi Health, Xiaoyusan, Baoxian Jike, U+ Health, Zhihui Shijue, Yuanxin HuibaoPending confirmation of attendance by distinguished guests.
| Time | Topic | Guest |
| Host | Jiang Guanjun | Partner, Mingde Actuarial | |
| 09:00-09:30 | Interpretation of Healthcare Insurance Reform Policies Under the 14th Five-Year Plan | Cai Jiangnan | Executive Chairman, Shanghai Chuangqi Health Research Institute |
| 09:30-09:50 | Unprecedented Changes in a Century: New Opportunities in the Health Insurance Sector Through Deep Integration with Smart Healthcare | Zhang Boyuan | Executive Director, Life Capital |
| 09:50-10:10 | Building a Complete Ecosystem from Payment to Services to Support the Development of a Multi-Tiered Medical Insurance System | Feng Hao | General Manager, Innovative Payment and Patient Services Division, MedxHealth |
| 10:10-10:30 | The Integration of Commercial Insurance Development with the Healthcare Industry | Guang Yao | Founder & CEO of Xiaoyusan Insurance Brokerage |
| 10:30-10:50 | Entering the market through high-frequency medical insurance to build a [Healthcare + Insurance Payment] closed loop | Li Shuo | Co-founder & COO of InsurGeek |
| 10:50-11:10 | Managed Care Empowers Innovation in Health Insurance Products | Wang Yanping | Founder & CEO of U+ Health |
| 11:10-11:30 | Assetization of Health Insurance Data and Big Data-Driven Integration of Healthcare and Insurance | Jiao Long | COO, Knowledge Vision |
| 11:30-11:50 | The Impact on and Opportunities for the Industry Behind the Gradual Standardization of City-Specific Inclusive Health Insurance | Peng Xuan | CEO of Yuanxin Huibao |

1. CombinationPreparatory Committee for Digital Therapeutics Systems Engineering, China Association for Promotion of Rehabilitation Technology Translation and Development; Yuanyi CapitalCo-hosted, with premium resources powerfully aggregated;
2. China’s first industry forum focused on digital therapeutics,“2021 China Digital Therapeutics White Paper”First Release: An In-Depth Analysis of Why Digital Therapeutics Will Ultimately Become a Blue Ocean Market;
3、Takeda Pharmaceutical, Sanofi, Philips, MerckAwaiting confirmation of attendance from the Head of Innovation.
| Time | Topic | Guest |
| Host | Yang Ruirong | Partner at Yuanyi Capital | |
| 14:00-14:20 | Opening Remarks | Song Wuchen | President-Elect and Executive Secretary-General, China Association for the Promotion of Rehabilitation Technology Translation and Development |
| 14:20-14:40 | Analysis of the Development Prospects of Digital Therapeutics Globally and in China | Li Sirui | General Manager, Strategic Development Center, Tasly |
| 14:40-15:00 | “2021 China Digital Therapeutics White Paper” Released | Jiang Tianjiao | Dean of VCBeat |
| 15:00-15:20 | How Digital Therapeutics Are Redefining Mobile Health | Dong Yufang | Head of China, Takeda China Innovation Incubator & Digital Advisory Board |
| 15:20-15:40 | The Development of Digital Therapeutics and Their Position in the Healthcare Sector | Xia Wenrong | Head of Innovation, Sanofi China |
| 15:40-16:00 | Reflections on Disease-Specific Course-of-Illness Management Platforms and Digital Therapeutics | Wan Ma | General Manager of Weimai AI Digital Therapeutics Center, Ph.D. |
| 16:00-16:20 | Exploration and Practice of Digital Therapeutics: A Sharing Session | Zhang Wei | Founder of Yongliu Technology |
| 16:20-16:40 | Lessons from Abroad: International Experience in Digital Therapeutics | Yang Ruirong | Partner at Yuanyi Capital |
| David Benshoof Klein | Co-founder and CEO of Click Therapeutics | ||
| Brent Vaughan | Cognito Therapeutics CEO | ||
| 16:40-17:20 | Digital Therapeutics Reshape the Chronic Disease Management Ecosystem: What Are the Innovative Models for the Future? | Moderator: Song Yiran | Investment Director, Yuanyi Capital |
| Li Yi | Acting Head of Merck China Innovation Center and Director of Innovation Incubation Investment | ||
| Liu Yunjiang | Founder and CEO of Yunkai Yamei | ||
| Zhang Wei | Founder of Yongliu Technology | ||
| Xia Wenrong | Head of Innovation, Sanofi China | ||
| Zhang Jing | Chairman and General Manager, Senmei Medical Technology | ||
| Dong Yufang | Head of China, Takeda China Innovation Incubator and Digital Advisory Board | ||
| 17:20-18:00 | Opportunities and Challenges of Digital Therapeutics in Brain Science | Host: Bi Yuanfeng | Co-founder and COO of VCBeat |
| Yongqin Zeng | Senior Director, Philips Ventures | ||
| Yan Jingjing | Founding Partner, Probe Capital | ||
| Zhang Zhiguang | Founder of AlsoLife | ||
| Wang Xiaoyi | CEO of Liuliu Brain, Ph.D. | ||
| Yongnan Ji | Director of Medical Applications, NVIDIA China | ||
| Ma Ke | Executive Director, Northern Light Venture Capital | ||

1. VCBeat in collaboration withBohou MedicalCo-hosted;
2. Aggregating digital services and product applications across multiple scenarios, fostering a new digital ecosystem for primary healthcare, etc.
| Time | Topic Direction | Guest |
| Host | Zhang Ying | Executive Director, M&A Investment Department, GF Xinde | |
| 14:00-14:20 | New Infrastructure for Primary Healthcare in the Post-Pandemic Era | Liao Xinbo | Former Deputy Director-General and Inspector of the Guangdong Provincial Health Department |
| 14:20-14:40 | A Decade of Pharmaceutical Investment and the Next Ten Years: Opportunities in the Primary Healthcare Market | Yu Wenxin | Chief Healthcare Analyst, Haitong Securities |
| 14:40-15:00 | Benefits of International Accreditation | Mr. Michael Giuliano | International Executive Director, ACHS |
| 15:00-15:20 | Digitalization-Led 3P Model Solves the Challenges of Chain Development in Primary Healthcare | Yan Honghui | Founder of BoHou Medical |
| 15:20-15:40 | Digital Smart Operations Empowerment Service Platform for Primary Healthcare | Zhang Chenchen | CEO of Mingyi Zhonghe |
| 15:40-16:00 | Building an All-Scenario Digital Platform to Enhance Patients’ Lifetime Value | Jiang Yiru | Co-founder of YiHu Baijia |
| 16:00-16:20 | Focusing on Digital Empowerment to Bridge the “Last Mile” of Public Health Physical Examinations | Jin Lei | CEO of Jianjian Family Doctor |
| 16:20-16:40 | Innovation · Collaboration — Integrated Solutions Empowering Primary Healthcare | Gao Lei | Head of Feiying Business Marketing, Commercial & Business Development Department, AstraZeneca |
| 16:40-17:20 | How to Open Up New Prospects for Primary Healthcare? Exploring a New Ecosystem of Collaboration | Moderator: Xie Kai | Partner, Fenxiang Investment Healthcare Fund |
| Roundtable Panelist: Zhang Suhua | Director, Institute of Social Medical Organizations, Shanghai Jiao Tong University | ||
| Cui Hongyu | General Manager of Innovation Technology, Omnichannel Business Unit, Microsoft (China) Co., Ltd. | ||
| Wang Lijue | Vice President of the China Pharmaceutical Material Association, Founder and Chairman of Akang Health Group | ||
| Xue Chong | Founder and CEO of Quanzhentong | ||
| Fan Minhua | Committee Member of the Party Committee, Jianggan District Health Commission, Hangzhou | ||

1. InvitationTigermed, KingMed Diagnostics, New Horizon Health, GE Healthcare, BOE, DHC Software, Genetron HealthChairman of a benchmark listed company releases the annual corporate strategy;
2. InvitationKunyuan Bio, DXY, Haodf Online, Xinyi International, Shanzhen, Miao Health, Meiwei DentalRepresentative enterprises from healthcare industry unicorns and the Future Healthcare 100 will share their new technologies, new models, new scenarios, and new ecosystems in industrial innovation practices.
| Time | Section | Agenda | Guest |
| Host | Liu Zongyu | Editor-in-Chief, VCBeat Content Center | ||
| 09:00-09:20 | Leader's Perspective: Listed Company Strategic Launch Event | Leading the Way, Leaping into the Future—Commercialization as the Core Competitiveness in the Second Half of China’s Pharmaceutical Innovation | Wang Ruwei | Deputy General Manager of Tigermed |
| 09:20-09:40 | Exploration and Practice of KingMed Diagnostics 4.0 | Xie Jiangtao | Rotating COO, Vice President, and General Manager of the East China Region at KingMed Diagnostics Group | |
| 09:40-10:00 | How Far Is the Vast Frontier of Early Cancer Screening? | Zhu Yeqing | Executive Director and CEO of New Horizon Health | |
| 10:00-10:20 | China's Digital + Healthcare Innovation Prescription: Comprehensive Domestic Production, Digital Empowerment, and Win-Win Cooperation | Yan Hua | Vice President and Chief Marketing Officer, GE Healthcare China | |
| 10:20-10:40 | A New Ecosystem for Health Management in the Internet of Things Era | Zhang Wei | Senior Vice President of BOE, Co-CEO of the Smart Medical Engineering Business Group | |
| 10:40-11:00 | HOS: Building Next-Generation Smart Hospitals Through Digital Twins | Wen Heng | Vice President of DHC Software Co., Ltd., Chief Consultant of DHC Medical | |
| 11:00-11:20 | Original Research Technology Empowers the Full Cycle of Precision Cancer Diagnosis and Treatment | Xu Ce | CFO of Genetron Health | |
| 11:20-11:40 | The Future Is Here: Exploring How Integrated Financial Services Empower the Digital Transformation of the Healthcare Industry | Zhu Min | General Manager, Medical Finance Department, Huarong Rongde Asset Management Co., Ltd. | |
| Lunch Break | |||
| Host | Wang Guanglong | General Manager of Egg Yolk Tech VB100 | ||
| 14:00-14:20 | Calculating the Future: The Path to Innovation for the Top 100 Enterprises | Seeing Is Believing: Reimagining the Future of Healthcare Through Innovative Services | Jiang Xiaodong | Managing Partner, Changling Capital |
| 14:20-14:40 | How to Build Future Competitiveness for Early Cancer Screening Products | Zhang Jiangli | Founder and CEO of Genetron Health | |
| 14:40-15:00 | New Trends in the Digital Marketing Transformation of the Pharmaceutical Industry in the Post-Pandemic Era | Li Tiantian | Founder of DXY | |
| 15:00-15:20 | What Is Truly “Patient-Centered” Internet Healthcare? | Wang Hang | Founder and CEO of Haodf Online | |
| 15:20-15:40 | Cloud-Edge-Network Collaboration to Realize the Value of Intelligent Healthcare Services | Tai Congyue | Co-founder and President, Heart Doctor International | |
| 15:40-16:00 | Reflections and Practices in the Parental Health Industry | Wu Hongxing | CEO of Shanzhen | |
| 16:00-16:20 | Empowering Insurance Upgrades Through Digital Health Management in the AIoT Era | Kong Fei | CEO of Miao Health | |
| 16:20-16:40 | Julia Zhu | Founding Partner and CEO of Meiwei Dental | ||
| 16:40-17:00 | Digital-Driven Upgrading and Innovation in Healthcare Services | Zhang Guodong | General Manager, Tencent Smart Healthcare | |

1、"Report on Digital Marketing in Pharmaceutical Companies"Major Announcement;
2. Focus on hot topics: basic cloud infrastructure + digital solutions, the closed-loop of digital marketing for pharmaceutical companies, the upgrade of digital marketing driven by the pandemic, and the exploration of new retail models supported by cloud data, etc.
| Time | Agenda | Guest |
| Host | Hong Yuandong | Founder of Siqi Circle | |
| 09:00-09:20 | MNCs’ Digital Innovation Logic in China | Ma Xi | Head of Market Access Innovation, Roche |
| 09:20-09:40 | "Research Report on Digital Marketing in the Pharmaceutical Industry" Released | Jiang Tianjiao | Dean of VCBeat Institute |
| 09:40-10:00 | Digital Transformation of Pharmaceutical Marketing in the Post-Pandemic Era | Gao Jianfei | Founder & CEO of Yibai Technology |
| 10:00-10:20 | Exploration of the New Retail Model Supported by Cloud Data | Du Tongjie | Vice President of Quanyuantang |
| 10:20-10:40 | How to Unlock the Maximum Value of Digital Marketing in the Pharmaceutical Industry | Yan Guowei | Founder of Qingyun Technology |
| 10:40-11:00 | Multi-Scenario, Omni-Channel Private Domain Traffic Operations | Lai Gangbin | Founder of Jingli Technology |
| 11:00-12:00 | Digital Marketing Upgrade Driven by Big Data | Host: Wu Binghong | Founder of Yibei.com |
| Roundtable Guest: Ye Dan | President of Shiqiang Pharmaceutical | ||
| Ma Xi | Head of Access Innovation, Roche | ||
| Li Yingli | President of Souyao.com | ||
| Du Tongjie | Vice President of Quanyuantang | ||

1、BaiRen Medical, Terumo, MedtronicPending confirmation of attendance by guest representatives;
2. Focus on hot topics such as overseas markets and payment-side changes following volume-based procurement, independent innovation in high-value consumables, and the marketization of high-value consumables amid frequent policy updates.
| Time | Agenda | Guest |
| Host | Zhang Zhiling | Deputy General Manager, Shanghai Institute of Microsystem and Information Technology Industrial Research Institute | |
| 09:00-09:20 | Reflections on Innovation in High-Value Medical Consumables | Zhu Guoguang | Chief Analyst, Soochow Securities |
| 09:20-09:40 | Volume-Based Procurement Becomes the Norm: How It Is Reshaping the High-Value Medical Consumables Industry | Jin Lei | CEO of BaiRen Medical |
| 09:40-10:00 | Practice of Coronary Functional and Imaging Technologies | Zheng Yuxiao | Head of Strategy and Expansion, Shenzhen Northcore |
| 10:00-10:20 | Can the Neurointerventional Sector Replicate the Success of Cardiovascular Intervention? | Zhao Zhong | Founder of ZC Medical |
| 10:20-10:40 | Applications and Technological Innovations of High-Value Consumables in Sports Medicine | Li Jianbo | Founder of Demei Medical |
| 10:40-11:00 | Investment Layout and Logic for High-Value Medical Consumables Reaching New Heights | Shi Yonghui | Managing Director, Medtronic China Fund |
| 11:00-11:20 | Technological Innovation Practices of the CH-VAD Artificial Heart | Chen Chen | Chairman of Tongxin Medical |
| 11:20-12:00 | # Where Is the Next Battlefield for Domestic Substitution in the First Year of the 14th Five-Year Plan? | Moderator: Ding Guanhua | Vice President, Chende Capital |
| Roundtable Panelists:Chen Chen | Chairman of Tongxin Medical | ||
| Zhang Wen | General Manager, Terumo Cardiovascular Business Division | ||
| Li Jianbo | Founder of Demei Medical | ||

1、VCBeatCombinedDolphin Internet Healthcare Industrial ParkCo-hosted: An In-Depth Analysis of the Era of Internet Healthcare Licenses;
2. Focus on hot topics such as the differentiated competition among thousands of internet hospitals and the entry into a new phase of cooperation with physical hospitals;
3、White Paper on Internet Hospitals Specializing in AndrologyMajor Announcement.
| Time | Topic | Guest |
| Host | Zhang Xiaoxu | Senior Researcher, VCBeat | |
| 09:00-09:20 | The Creation and Exploration of the Internet + Medical Health Ecosystem in the Yinchuan Model | Yuan Fang | Director, Information Department, Yinchuan First People's Hospital |
| 09:20-09:40 | Analysis of the Current Cycle in the Internet Hospital Industry | Tian Min | Partner at Yuanjing Capital |
| 09:40-10:00 | The Dilemmas, Reflections, and Breakthroughs of Internet Hospitals | Yang Jianchun | Dean of Baidu Health Internet Hospital |
| 10:00-10:20 | Introduction to the Chengdu Internet Healthcare Industrial Park | Wu Hao | CEO of Taozi Internet Hospital |
| 10:20-10:40 | White Paper on Internet Hospitals Specializing in Andrology Released | Wang Chenhao | Researcher, VCBeat |
| 10:40-11:00 | The Internet Healthcare Industry and Public Medical Resources: The Path to Balanced Dual Wings | Yue Yifeng | Vice Chairman and General Manager of Huaxi Public Utilities |
| 11:00-11:20 | How Internet Healthcare Can Truly Enable Physicians to Realize Their Professional Value | Chang Jiang | Founder of Umai Technology |
| 11:20-12:00 | Development Positioning and Strategic Considerations for Internet Hospitals in China: Driven by Policy Guidance and Market Forces | Moderator: Chen Qiulin | Deputy Director of the Health Industry Development Research Center, Chinese Academy of Social Sciences; Deputy President of Contemporary China Publishing House |
| Roundtable Panelist: Wu Fang | Assistant President of Yuanxin Technology Group · General Manager of Yuanxin Medical | ||
| Yang Jianchun | Dean of Baidu Health Internet Hospital | ||
| Wu Hao | CEO of Taozi Internet Hospital | ||
| Lu Tao | General Manager of Zhiben Internet Hospital | ||

1. CombinationGuangdong Zhong Nanshan Medical Foundation, Chuangrui Investment, China Clinical Research Consortium, UK Beyond LabCo-hosted;
2. Supporting Organizations: Yarui Capital, Zhongguancun Zhiyou Scientist Fund, Tsinghua University Global Health Industry Innovation Center, Sichuan Western Medical Technology Transfer Center, Sichuan International Medical Exchange Promotion Association, Sinovation Ventures;
3. InvitationBeihang University, Tsinghua University, Sichuan University, University of Shanghai for Science and Technology, University of Oxfordguests from top-tier universities;
4. InvitationCleveland Clinic, Peking Union Medical College Hospital, West China Hospital, Xiangya Hospitalrepresentatives from top-tier hospitals.
| Time | Agenda | Guest |
| Host | Yin Xuejiao | Director, International Medical and Health Technology Transfer Platform, Yi Cu Hui | |
| 13:30-13:40 | Address | Li Datao | Founder of VCBeat |
| Han Wenxin | Co-Convenor and Secretary-General of the China Clinical Research Community | ||
| 13:40-14:00 | Scientists and Angels: The Practice of Translating Scientific Achievements into Public Listings | Wang Tianmiao | Professor, Beihang University |
| 14:00-14:20 | CCI System Innovation Engine Incubating Nearly 100 Companies in 2021 | Tom Sudow | Director of Business Development, Cleveland Clinic Innovations |
| 14:20-14:40 | The Path to Innovation in Joint Robotics, Focused on Clinical Value | Lin Jin | Chief Physician, Department of Orthopedics, Peking Union Medical College Hospital |
| 14:40-15:35 | Commercialization of Scientific Research Achievements from Top Institutions in China and the United States | Moderator: Tang Haofu | Chairman of Chuangrui Investment |
| Guest Speaker: Chongqing Medical University (Invitation Pending) | ||
| Lei Juan | Deputy Director, West China Transfer Center, West China Hospital, Sichuan University | ||
| Zhang Dawei | Dean of the Institute for Technological Development, University of Shanghai for Science and Technology | ||
| Sidney | Professor at Mount Sinai Hospital | ||
| Wang Tianmiao | Professor, Beihang University | ||
| 15:35-16:15 | Exploration of a Complete Ecosystem Pathway: From Research and Findings to Translation and Industrialization | Moderator: Geng Jia | Professor at Sichuan University, Distinguished Researcher at the State Key Laboratory of Biotherapy |
| Guest Speaker: Wang Jingjing | Executive Director, Global Health Industry Innovation Center, Tsinghua University | ||
| Ma Li | General Manager of New Nest | ||
| Huang Yangbin | General Manager and Dean, Wuhan Optics Valley Asia-Pacific Pharmaceutical Research Institute | ||
| Fang Li | Director of the Xiangya Medical Division, Intellectual Property Center of Central South University | ||
| 16:15-16:35 | The Model of Technology Transfer and Commercialization at the University of Oxford | Jane Jin | Head of China, Oxford University Technology Transfer Office |
| 16:35-16:55 | The Translational Story and Reflections Behind Keytruda | Zhi Zhang | Business Development Manager, Technology Division, UK Medical Research Council |
| 16:55-17:35 | Where Is the Path Forward for Scientists’ Innovation Models? | Moderator: Ren Bobing | Executive Director, Sinovation Ventures |
| Guest Speaker: Zhangwei Luo | Chief Scientist, Suzhou Smart Healthcare Innovation Center; Former Chief AI Scientist, Siemens China Research Institute, Suzhou Branch | ||
| Yin Xuejiao | Director, International Medical and Health Technology Transfer Platform, Yicuhui | ||
| Sun Jingsheng | Executive Vice Chairman of the Clinical Trial Branch of the China Association for Medical Device Industry, Former Director of the Medical Device Registration and Supervision Division of the Beijing Municipal Drug Administration | ||

1. VCBeat in collaboration withWeituo BiotechCo-hosted;
2、Research Report on the Assisted Reproductive Technology IndustryMajor Announcement.
| Time | Agenda | Guest |
| Host | Lu Qinchao | Founding and Managing Partner of Danlu Capital | |
| 14:00-14:30 | Interpretation of Regulatory Policies for the Assisted Reproductive Technology Industry | Fan Yanjun | Assistant Director of the Center for Maternal and Child Health, Chinese Center for Disease Control and Prevention; Chair of the Special Committee |
| 14:30-15:00 | Anchoring on Real Demand: Domestic Substitution and Industry Chain Empowerment—2021 Research on the Assisted Reproductive Technology Industry | Shi Anjie | Senior Researcher, VCBeat |
| 15:00-15:30 | The Path to Domestic Production of Medical Devices for Assisted Reproductive Technology | Lin Xiaozhen | Chairman of Weituo Bio |
| 15:30-16:00 | New Business Models in Internet Healthcare for Assisted Reproduction | Sun Chunguang | Co-founder of Haoyunbang |
| 16:00-16:30 | How Assisted Reproductive Technology (ART) Clinics Can Build Brand Equity | Hu Bo | Founder of Ciming Boao International Hospital |
| 16:30-17:00 | New Opportunities for Investment and Development in the Assisted Reproductive Technology Market | Lu Qinchao | Founding and Managing Partner of Danlu Capital |

1. VCBeat in collaboration withVCBeat CapitalCo-hosted;
2. Focus on hot topics such as the development of data intelligence in the health industry, changes in traffic patterns, digital upgrades, and innovative collaboration models.
| Time | Agenda | Guest |
| Host | Liu Zongyu | Editor-in-Chief, VCBeat Content Center | |
| 14:00-14:20 | The Path to Digital Transformation in Big Health Under the New Strategy of the Data Industry | Tan Jianfeng | Member of the National Committee of the Chinese People's Political Consultative Conference, President of the Shanghai Information Security Industry Association |
| 14:20-14:40 | New Payment, New Entry Point, New Ecosystem | Zhao Yang | Partner, Weilai Capital |
| 14:40-15:00 | By-Health's Path to E-commerce Digitalization | Yin Xin | Chief Business Officer of By-Health |
| 15:00-15:20 | Data Intelligence Ushers in a New Era of Health Insurance Marketing | Xiang Liang | Founder of Shuming Technology |
| 15:20-15:40 | New Retail Era: How Prescription Drugs Can Break Through the Wind | Xia Yu | Founder of Dekai Pharma |
| 15:40-16:00 | Medical Device Ecosystem Innovation and Scenario Transformation Amidst Major Shifts in the Pharmaceutical Industry | Kang Kai | Founder of Xiyu Health |
| 16:00-16:20 | Private Domain Digital Intelligence Fuels the New Wave of Healthcare Consumption | Wei Zijun | Founder of Dianran Technology |
| 16:20-16:40 | Huamei Haolian: Building a Chinese-Characteristic, Upgraded Version of UnitedHealth Group | Xu Bingyu | Founder and CEO of Huamei Haolian |
| 16:40-17:20 | How Data Intelligence Empowers the New Ecosystem Amid Payment Innovation and Transformation | Host: Zhao Yang | Partner at Weilai Capital |
| Roundtable Guest: Tan Jianfeng | Member of the National Committee of the Chinese People's Political Consultative Conference, President of the Shanghai Information Security Industry Association | ||
| Yin Xin | Chief Business Officer of By-Health | ||
| Xiang Liang | Founder of Shuming Technology | ||
| Xia Yu | Founder of Dekai Pharmaceutical | ||
| Kang Kai | Founder of Xiyou Health | ||
| Wei Zijun | Founder of Dianran Tech | ||

1. VCBeat andYangtze River Delta Integration Demonstration Zone (Suzhou) Venture Capital Service Co., Ltd.Co-hosted;
2. Provide GPs with opportunities for in-depth, face-to-face exchanges with global LPs.Warm reminder: This summit is a closed-door event, requiring separate registration and approval.
| Time | Section | Agenda | Guest |
| Host | Yan Jingjing | Founder, Probe Capital | ||
| 09:30-09:40 | Guest Speech | Address | Deputy District Mayor of Wujiang District in charge |
| 09:40-10:00 | Boiling Years | Insights into the Changing Times: The Next Decade of Healthcare Investment in China (Tentative) | Wu Xia | Managing Director, CICC Capital |
| 10:00-10:50 | Reconstructing Aesthetics | Discussing the Chinese-Style LP-GP Relationship: The Healthcare Sector | Host: Xu Hong | Partner, Heju Yinuo Grand Health Industry Fund |
| Zhang Yanhong | Deputy Secretary of the Party Committee and General Manager of Suzhou Wujiang Dongfang State-owned Assets | |||
| Wang Xiaohui | Managing Partner, Shengjing Jiacheng Fund of Funds | |||
| Hu Chuanwei | Vice President, Hengqin Jintou Group | |||
| Li Yuhui | Founding Managing Partner, Panlin Capital | |||
| Yu Zhengkun | Founding Partner of Jifeng Capital | |||
| Tea Break | |||
| 11:00-11:35 | Specialized Roadshow | Tang Haofu | Managing Director, Chongqing Dianshi Chuangjian Fund Management | |
| Lunch & Lunch Break | |||
| 14:00-14:20 | The Intelligent Investor | R&D-Driven Investment in Biosciences | Liu Yu | Managing Partner, BGI Win-Win |
| 14:20-15:10 | The Great Game | Review of the 2020 IPO Market for Healthcare Companies and Future Outlook | Moderator: Luo Jiarong | Chief Analyst, GF Securities |
| Zhou Yi | Partner, SCGC Health Industry Fund | |||
| Li Jiangfeng | Partner and Managing Director, Fortune Star Medical Fund | |||
| Ma Ke | Executive Director, Northern Light Venture Capital | |||
| Xu Ce | Chief Financial Officer of Genetron Health | |||
| Tea Break | |||
| 15:20-16:10 | The Singularity Is Near | The Debate on CVC Investment in Healthcare | Moderator: Xu Qian | Partner at DT Capital Partners |
| Yang Ce | General Manager, Investment, Alibaba Health | |||
| Hou Xiaoxi | General Manager, Haier Medical Fund | |||
| Wu Aimin | Partner and President, Sinopharm Capital | |||
| Li Fan | Partner and Managing Director, Fosun Venture Capital | |||
| Zhou Hui | General Manager, Ping An Ventures | |||
| 16:10-17:00 | How to Build a New Healthcare Ecosystem Integrating Industry and Finance? | Moderator: Cao Yun | Director of Investor Relations, Shengshan Asset Management | |
| Gu Yan | Party Secretary and Chairman of the Board, Suzhou Wujiang Dongfang State-owned Assets Supervision and Administration Commission | |||
| Gan Shixiong | Founding Partner, Shengshan Capital | |||
| Xu Daqiang | Chief Business Officer, WuXi Biologics Group | |||
| Li Datao | Founder of VCBeat | |||
| 17:00-17:40 | Closed-Door Exchange | ||
1. VCBeat in collaboration withUK Beyond Laboratory, Huanyu Health, MSQCo-hosted;
2、UK, US, Canada, Belgium, Germany, Middle Eastoverseas experience in industrial development;
3、Microsoft, Intel, Amazon, IBM, Hims & Hers, Insilico, Viome,Livongo & VivanteSenior executives from high-quality overseas enterprises have confirmed their attendance.
| Time | Section | Agenda | Guest |
| Host | Qi Hong Bu | VCBeat Overseas Advisor | ||
| 9:00-9:05 | Conference Address | Address | Li Datao | Founder of VCBeat |
| 9:05-9:25 | Digital Healthcare Empowerment and Practice | The Global Frontier of Pharmaceutical Innovation and China’s Challenges | Wang Gang | Chief Scientist, Greater China, Clarivate |
| 9:25-9:45 | Co-building a Digital Healthcare Cloud Ecosystem to Empower Chinese Healthcare Enterprises in Going Global | Tao Ran | General Manager, Commercial Cloud Solutions, Microsoft Greater China | |
| 9:45-10:10 | AI-Empowered Digital Transformation and Innovation in Pharmaceutical Companies | Moderator: Bi Yuanfeng | Co-founder of VCBeat | |
| Li Jian | Head of Intel’s Healthcare and Life Sciences Innovation Business, Asia-Pacific | |||
| Huang Qingchun | Director of Healthcare and Life Sciences, Amazon AWS | |||
| 10:10-10:30 | AI Accelerates New Drug Development | Ren Feng | Chief Scientific Officer, Head of Drug Discovery at Insilico Medicine | |
| 10:30-10:50 | How to Promote Better Patient Engagement in Decentralized Clinical Trials | Ching Tian | Senior Vice President, Medable | |
| 10:50-11:10 | Advances and Challenges in Personalized Nutrition and Health | Naveen Jain | Founder and Chairman of Viome | |
| 11:10-11:30 | Current Status and Future of Digital Therapeutics | Innocent Clement | Founder of Ciba Health | |
| 11:30-12:10 | Trends in the Development of Health and Medical Technology | Host: Bu Qihong | VCBeat Overseas Consultant | |
| Kimon Angelides | Founder of Livongo & Vivante | |||
| Sandeep Makhijani | Head of IBM Watson Health, Asia Pacific | |||
| Leon Leong | Fenda Smart Technology CEO & Spring Ventures CEO | |||
| Patrick Carroll | Chief Medical Officer, HIMS&HERS | |||
| Lunch Break | |||
| 14:00-14:20 | Global Regional Economic Innovation | Overview of the Biopharmaceutical Industry and Investment Opportunities in Flanders, Belgium | Bart Boschmans (Lin Bosen) | Consul for Flanders Business, Consulate General of Belgium in Shanghai |
| 14:20-14:40 | Ontario, Canada – The Gateway to North American Life Sciences | Song Yijun | Canadian Consul in China & Chief Representative of Ontario in China | |
| 14:40-15:00 | Practical Experience in the Transfer of Technological Innovations in Asian Medical Research in Canada | Chen Fangxia | Director of Business Development, Asia Technology Transfer Centre, Western University, Canada | |
| 15:00-15:20 | Acceleration and Ecosystem Building for China-Canada Innovation | Wang Tong | Co-Founder, China-Canada Angel Alliance and Zhongguancun Dahe Capital | |
| 15:20-15:40 | Europe’s Premier Hub for Investment and Collaboration in the Pharmaceutical and Healthcare Industries | Xu Jun | Executive Chief Representative, Nanjing Office of Germany’s North Rhine-Westphalia International Business Agency | |
| 15:40-16:00 | Digital Healthcare Ecosystem and Development Trends in the Middle East | Louiza Chitour | Project and Partnership Manager, Plug and Play Tech Center | |
| 16:00-16:40 | Discussion on the Digital Innovation Development and Trends in the Pharmaceutical Industry | Xiaoan Daxia | MSQ Partner | |
| Tan Yan | CEO of Xbiome | |||
| Zeng Hainian | CEO, Suikun Intelligent Technology | |||
| Chen Chi | Chairman of BayHelix Group | |||
| Zhou Lei | Chairman of Huanyu Health Group | |||
| Guowei Su | Vice President, Greater China Region, SmileDirectClub (SDC) | |||
| Zhu Huaxing | Chairman of Nearshore Protein | |||
| 16:40-17:00 | How AI Empowers Personalized Diagnosis and Treatment | Michael Wilkinson | CEO and Founder of Inavya | |
| 17:00-17:20 | Current Status of Digital Healthcare Development in the UK and the Extensive Impact of Digital Medical Technologies | Nick Rodgers | Chairman of the South East Academic Health Science Network, UK; Chairman of Destiny Pharma | |
| 17:20-17:40 | The Digital Wave in Healthcare and Life Sciences | Hilary Thomas | KPMG UK Chief Medical Advisor | |
| 17:40-18:00 | R&D of New Drugs for Rare Diseases and China-UK Cooperation | Zhou Lu | CEO, UK Beyond Lab | |

1. VCBeat Joins Hands withJD HealthCo-hosted;
2、Smart Hospital HIS Industry Research ReportMajor Announcement;
3. Explore hot topics such as next-generation HIS systems, cloud computing, hospital cloud migration, and smart hospital service ratings.
| Time | Topic | Guest |
| Host | Zheng Yufen | Founder of Yueyin Medical Fund | |
| 09:00-09:20 | Practice and Exploration of the Operational Models of Traditional Chinese Medicine Hospitals in the Internet Era | Ren Xianqing | Vice President, The First Affiliated Hospital of Henan University of Chinese Medicine |
| 09:20-09:40 | Exploration of Models for Hospital Smart Management Construction Under the New Paradigm | Wei Xuejie | Vice President of the General Hospital of Xuzhou Mining Group |
| 09:40-10:00 | Exploration and Practice of Cloud-Native Regional Integration | Hong Xiaoqing | Director, Lianzhong Consulting |
| 10:00-10:15 | Embracing Change and Adaptability: Reflections on the Informatics Needs of Primary Healthcare | Yin Hong | Deputy Director of the Education, Health and Sports Bureau (Medical Security Administration) of Xixian New Area, Shaanxi Province; Director of the Public Health Management Center of Xixian New Area |
| 10:15-10:30 | The Path to Healthy Cities: Internet-Empowered Construction of New Scenarios for Primary Healthcare | Liu Mingyan | General Manager of JD Health's Healthy Cities Division |
| 10:30-10:50 | Future Exploration of the Smart Medical Community Platform | Zhou Zanhe | Founder and Chairman of Heyu Health |
| 10:50-11:10 | Data-Intelligence Driven: Building a New Ecosystem for Smart Healthcare | Wang Dongyuan | General Manager, Smart Healthcare, JD Health |
| 11:10-11:25 | “Smart Hospitals Drive Comprehensive Transformation of Hospital Architecture, Hospital Information Management System Restructuring Underway—Research on the New Generation HIS Industry” Report Released | Zhao Hongwei | Senior Researcher at VCBeat |
| 11:25-12:00 | Reflections on the Future Form of Smart Hospitals in the Wave of Digitalization | Moderator: Chen Yusi | Senior Investment Manager, GGV Capital |
| Roundtable Panelist: Wang Dongyuan | General Manager, JD Health Smart Healthcare | ||
| Ye Xin | Deputy Dean, Yilianzhong Beijing Research Institute | ||
| Zhou Zanhe | Founder and Chairman of Heyu Health | ||

How Can the Health Management Industry Create Opportunities and Meet Challenges Amidst the Trend of Chronic Diseases Affecting Younger Populations, an Aging Population, and Intensifying Market Competition?
| Time | Agenda | Guest |
| Host | Yu Jurong | CFO and Board Secretary of Yibao Health, Partner at Heju Yinuo Big Health Industry Fund | |
| 09:00-09:20 | The “Chinese Model” of Internet+ Chronic Disease Management | Yang Wenlin | CPO and Group Vice President of Zhiyun Health |
| 09:20-09:40 | “Health Services + Insurance Products” Model Empowers Innovative Practices in the Core Insurance Business | Li Qi | Deputy General Manager, Pacific Healthcare Management Co., Ltd. |
| 09:40-10:00 | Algorithm-Driven Dual-Channel Healthcare Model Leads the New Wave of Medical and Health Innovation | Wang Xu | Deputy General Manager of iKang Group and Deputy General Manager of Daoyitong Operations |
| 10:00-10:20 | Deepening Smart Health to Foster a New Paradigm for Urban Health Industry Development | Li Yuxin | Founder and Chairman, Health Benefit |
| 10:20-10:40 | Big Data-Enabled New Model for Full-Course Traditional Chinese Medicine Health Management | Cao Xueli | CEO of Shangyi Renjia |
| 10:40-11:00 | IoT-Driven Innovation in Home Healthcare Services | Ma Ji | Co-Founder and Chief Medical Officer of Yilianjia Platform |
| 11:00-11:20 | The Future of Smart, Precision Management of Chronic Respiratory Diseases | Pan Tao | Co-Founder of Huichang CloudMed |
| 11:20-12:00 | Surging Trends: Opportunities and Challenges in Industrial Leapfrogging | Moderator: Yu Jurong | CFO and Board Secretary of Yibao Health, Partner at Heju Yinuo Big Health Industry Fund |
| Roundtable Guest: Liu Yan | Founder of Anhe Health | ||
| Wang Xu | Deputy General Manager of iKang Group and Deputy General Manager of Operations at Daoyitong | ||
| Li Shuo | Co-founder & COO of Insurance Geek | ||
| Yue Hongwen | President of Boao Yiling Cardiovascular Hospital | ||
| Cao Xueli | CEO of Shangyi Renjia | ||
| Li Yuxin | Founder and Chairman of HealthBenefit | ||

1. VCBeat Partners with5Y CapitalCo-hosted, Defining ITBT;
2. Focus on hot topics such as the application of AI in new drug development and the emergence of next-generation application categories.
| Time | Agenda | Guest |
| Host | Zeng Ying | EIR (Entrepreneur in Residence) at Source Code Capital | |
| 09:00-09:25 | 5Y Capital’s ITBT Investment Practice: Why We Are Firmly Bullish on Digital Drug R&D? | Jing Xutian | Managing Director, Wuyuan Capital |
| 09:25-09:50 | Drug Innovation Driven by Digitalization and Intelligence | Wen Shuhao | Co-founder and Chairman of XtalPi |
| 09:50-10:15 | Implementation and Value of Digital Transformation in Clinical R&D for Pharmaceutical Companies | Ma Dong | Partner at Taimei Medical Technology |
| 10:15-11:00 | How Can Computation and AI Break Through the Traditional Paradigm of New Drug Development? | Moderator: Li Yang | Founder and CEO of Anji Kang'er |
| Li Chengtao | Founder & CEO of StarryPharm Technology | ||
| Lai Caida | CEO of METiS Pharmaceuticals | ||
| Chen Hang | Co-founder and CEO of Xingkangyuan Biology | ||
| 11:00-11:40 | Next-Generation Computing + Experimentation: The Emergence of New Application Categories | Host: Wen Wen | Founder and CEO of Huanyi Bio |
| Guest: Tan Yan | CEO of XBiome | ||
| Wang Yuchong | Founder and CEO of ChenAn Biologics | ||
| Ji Xuwu | Founder of Purui Benchmark Technology | ||
| Qian Weiwen | Deputy General Manager of Wu Gan Pharmaceutical | ||
| 11:40-12:00 | "Regulatory Implementation: Comprehensive Application from Pharmaceuticals to Medical Devices—Industry Research on Real-World Studies" | Hao Han | Senior Researcher, VCBeat |

1. VCBeat Joins Hands withMingfeng CapitalCo-hosted by the Leading Medical Aesthetics CompanyAimei KeConfirm attendance;
2. Focus on hot topics such as emerging biotech players and breakthroughs in new materials, the hair transplantation and body contouring markets, and platform competition in the era of mass-market adoption of non-surgical medical aesthetics.
| Time | Agenda | Guest |
| Host | Hu Xuan | Senior Analyst, VCBeat | |
| 13:30-13:50 | Value Distribution in the Medical Aesthetics Industry Chain | Jin Xuekun | Founding Partner, Mingfeng Capital |
| 13:50-14:10 | Lessons from Abroad: Insights from Global Aesthetic Medicine Industry Experience for Investment in China’s Aesthetic Medicine Market | Chen Long | Head of Investment, Imeik |
| 14:10-15:00 | New Breakthroughs in Upstream Technologies and Materials for the Medical Aesthetics Industry, Along with Investment Rationale | Moderator: Fei Simin | Partner at Mingfeng Capital |
| Roundtable Guest: Wang Zhen | Partner, Mingfeng Capital | ||
| Yan Jingran | Executive Director, Honghui Capital | ||
| Song Gaoguang | Partner, Northern Light Venture Capital | ||
| Lin Lei | General Manager, CCB International Healthcare Growth Fund | ||
| 15:00-15:50 | The Medical Aesthetics Body Contouring Market Is Poised for an Explosive Boom: How Can Medical Aesthetics Service Providers Seize the Opportunity? | Moderator: Hu Xuan | Senior Analyst, VCBeat |
| Guest: Li Yong | Managing Director, Chengdu Badachu | ||
| Zhao Heng | General Manager, Langzi Medical Aesthetics | ||
| 15:50-16:10 | The "Future" Market of Hair Transplantation in China | Li Xingdong | Founder of Daimai Micro-needle Hair Transplant Global Chain Hospitals |
| 16:10-16:30 | AI-Powered SaaS Solutions Drive the Development of the Traditional Medical Aesthetics Industry | Liu Hongyu | Operations Director and Chief Traffic Officer, Lanshi Technology |
| 16:30-16:50 | Dissolving Microneedle Drug Delivery Technology and Industrialization | Jiang Lin | Founder of Qinglan Bio |

1. VCBeat joins hands withEarly Screening NetworkCo-hosted, with deeply specialized topics
2、2021 Report on the Early Cancer Screening IndustryMajor Announcement;
3、BGI Group, Dian Diagnostics, Rendong Medicine...and other corporate executives have confirmed their attendance.
| Time | Topic | Guest |
| Host | Chen Zanquan | CEO/Co-founder of Zaoshai.com | |
| 13:30-13:50 | Investment Hotspots and Value Amidst Industry Leapfrogging | Zhou Quan | Managing Director, Legend Capital |
| 13:50-14:10 | Technological Development and Innovation Directions in Early Cancer Screening | Zhu Shida | Commander-in-Chief of BGI's Domestic "Fire Eye Laboratory," Director of BGI's R&D Center, and Head of the Oncology Business Unit |
| 14:10-14:30 | Emerging Giants, Product Upgrades—2021 Industry Report on Early Cancer Screening | Wang Shiwei | Researcher at VCBeat |
| 14:30-14:50 | China’s Early Cancer Screening Program Based on HIFI Technology | Zhou Jun | CEO, Herui Gene |
| 14:50-15:10 | Application of DNA Methylation Detection Technology in Early Cancer Screening Products | Zhang Lianglu | Founder and General Manager of Amison |
| 15:10-15:30 | From Detection to Early Screening: Business Exploration | Yan Linghua | CEO of Tree Genetics |
| 15:30-15:50 | Early Screening and Prognostic Diagnosis of Bladder Cancer | Chen Gang | Founder and CEO of Kanglu Bio |
| 15:50-16:10 | Research on Integrated Solutions for Precision Diagnosis and Treatment of Early-Stage Lung Cancer Based on Domestic Electromagnetic Navigation Systems | Yi Xin | Chairman and General Manager of Suzhou Langkai Medical |
| 16:10-17:00 | New Opportunities in the Blue Ocean Market for Early Cancer Screening | Chen Zanquan | CEO/Co-founder of Zaoshai.com |
| Shen Qin | Partner at Shengyu Investment | ||
| Zhu Shida | Commander-in-Chief of BGI’s “Fire Eye Laboratory” in China, Director of BGI’s R&D Center, and Head of the Oncology Business Unit | ||
| Jiang Tang | Senior Vice President and Chief Strategy Officer, Dian Diagnostics | ||
| Zhu Ruixin | Vice President of Bioinformatics, Rendong Medical Group | ||
| Yan Linghua | CEO of Tree Genetics | ||

(Scan the QR code to register and get an instant discount of 100 yuan)